Related Experiment Video
Updated: Jul 14, 2026

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
Published on: September 17, 2021
Coronary Artery Vasospasm: Cellular and Molecular Insights
Stefan Juricic1, Milan Dobric2,3, Sinisa Stojkovic1,2
1Clinic of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Insights
Coronary artery vasospasm (CAV) is a reversible narrowing of heart arteries causing ischemia. Understanding its complex pathophysiology involving vascular smooth muscle cells and endothelial dysfunction is key to developing new treatments.
Area of Science:
- Cardiology
- Vascular Biology
- Molecular Medicine
Background:
- Coronary artery vasospasm (CAV) causes reduced blood flow and myocardial ischemia, often underdiagnosed.
- CAV presents with chest pain, acute coronary syndrome, arrhythmias, or sudden cardiac death.
- Vasospasm occurs in normal arteries or atherosclerotic lesions.
Purpose of the Study:
- To elucidate the multifactorial pathophysiology of coronary artery vasospasm.
- To identify molecular mechanisms underlying vascular smooth muscle cell hyperreactivity and endothelial dysfunction.
- To highlight potential novel therapeutic targets for refractory CAV.
Main Methods:
- Review of molecular mechanisms of vascular smooth muscle cell contraction and relaxation.
- Analysis of the role of endothelial dysfunction, inflammation, and autonomic dysregulation in CAV.
- Examination of signaling pathways including Rho-kinase (ROCK).
Main Results:
- CAV pathophysiology involves vascular smooth muscle cell (VSMC) hyperreactivity, endothelial dysfunction, inflammation, and autonomic dysregulation.
- Key mechanisms include increased intracellular calcium, Rho-kinase (ROCK) mediated inhibition of myosin light chain phosphatase (MLCP), and reduced nitric oxide bioavailability.
- Chronic inflammation and oxidative stress exacerbate VSMC contraction and endothelial dysfunction.
Conclusions:
- Understanding the molecular basis of CAV is crucial for therapeutic advancements.
- Emerging strategies targeting ROCK, endothelin receptors, and inflammation show promise for managing refractory CAV.
- Further research into these pathways may improve clinical outcomes for patients with CAV.
Abstract:
Coronary artery vasospasm (CAV) is a transient, reversible constriction of the epicardial coronary arteries that reduces coronary blood flow and may cause myocardial ischemia. Despite its clinical significance, CAV remains underdiagnosed and can present as chest pain, acute coronary syndrome, malignant arrhythmias or sudden cardiac death. Vasospasm may occur in both angiographically normal coronary arteries and at sites of pre-existing atherosclerotic stenosis. The pathophysiology of CAV is multifactorial and involves vascular smooth muscle cells (VSMCs) hyperreactivity, endothelial dysfunction, chronic inflammation and autonomic dysregulation. VSMCs contraction is mediated by phosphorylation of the myosin light chain (MLC) through calcium (Ca2+)/calmodulin-dependent myosin light chain kinase (MLCK), while relaxation is regulated by myosin light chain phosphatase (MLCP). Increased intracellular Ca2+ levels and enhanced Ca2+ sensitivity contribute to excessive vasoconstriction. Rho-kinase (ROCK) plays a pivotal role in sustained vasospasm by inhibiting MLCP, thereby promoting prolonged smooth muscle contraction. Endothelial dysfunction contributes to CAV by disrupting normal vascular tone regulation, largely as a result of decreased nitric oxide (NO) mediated vasodilation. Chronic low-grade inflammation and oxidative stress exacerbate both endothelial dysfunction and VSMCs contraction. Understanding these molecular mechanisms is essential for identifying novel therapeutic targets. Emerging treatment strategies, including ROCK inhibitors, endothelin receptor antagonists and anti-inflammatory agents, may improve outcomes in patients with refractory CAV.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Vascular Spasm
Myocarditis I: Introduction
Inflammatory Response I: Vascular and Cellular
Coronary Artery Disease I: Introduction

